Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients.
Alessio GerussiCristina RigamontiChiara EliaNora CazzagonAnnarosa FloreaniRoberta PozziPietro PozzoniErnesto ClaarLuisa PasuloStefano FagiuoliLaura CristoferiMarco CarboneInvernizzi PietroPublished in: Hepatology communications (2020)
Patients under immunosuppressive therapy for AIH developing COVID-19 show a disease course presumptively similar to that reported in non-immunosuppressed population. These data might help medical decision when dealing with SARS-CoV-2 infection in immunocompromised patients.